EnWave is an innovative R&D company driving the development of a new industry standard for food and pharmaceutical dehydration. Our goal is to provide manufacturers with novel technology that is faster, more cost-effective, and produces a higher quality end product than conventional methods of dehydration.
Our current technology dates back to 1996 with the development of the first Radiant-Energy Vacuum (REV) machine at the University of British Columbia for dehydrating food and nutraceuticals. Since then, we have gone on to produce a number of better, more efficient designs; tested them on a wide variety of food products; and developed a new, highly-controlled machine to dehydrate liquid pharmaceuticals.
We now have two distinct divisions of the company: bioREV for liquid pharmaceutical dehydration and nutraREV for food dehydration. Commercialization of nutraREV may begin as early as 2008, if our current commercial-scale testing proves successful. Our bioREV technology is undergoing prototype testing by a pharmaceutical partner to establish baseline data for comparison with freeze-drying. Our goal is to become the “gold-standard” for dehydration in both the food and biomedical sectors.
| EnWave Closes $1 million Private Placement | 06/02/2008 - 07:00 | $1Million |
| EnWave Announces $875,000 Private Placement | 05/06/2008 - 07:00 | $0Million |